Key result
Helium conditioning accelerated the migration of neonatal rat cardiac fibroblasts but did not increase activation markers or release protective extracellular vesicles or soluble factors.
Why the study?
Helium inhalation confers cardioprotection against ischemia/reperfusion injury, but the cellular mechanisms and whether extracellular vesicles mediate helium conditioning remain unelucidated.
Helium conditioning accelerates cardiac fibroblast migration, potentially contributing to cardioprotection against ischemia/reperfusion injury, but this effect is not mediated by extracellular vesicles or soluble factors.
Answers are grounded in this paper and cite their sources.
Helium conditioning may act via fibroblast EVs in cardioprotection; leaves open clinical translation to ischemia/reperfusion injury.
Helium inhalation induces cardioprotection against ischemia/reperfusion injury, the cellular mechanism of which remains not fully elucidated. Extracellular vesicles (EVs) are cell-derived, nano-sized membrane vesicles which play a role in cardioprotective mechanisms, but their function in helium conditioning (HeC) has not been studied so far. We hypothesized that HeC induces fibroblast-mediated cardioprotection via EVs. We isolated neonatal rat cardiac fibroblasts (NRCFs) and exposed them to glucose deprivation and HeC rendered by four cycles of 95% helium + 5% CO2 for 1 h, followed by 1 h under normoxic condition. After 40 h of HeC, NRCF activation was analyzed with a Western blot (WB) and migration assay. From the cell supernatant, medium extracellular vesicles (mEVs) were isolated with differential centrifugation and analyzed with WB and nanoparticle tracking analysis. The supernatant from HeC-treated NRCFs was transferred to naïve NRCFs or immortalized human umbilical vein endothelial cells (HUVEC-TERT2), and a migration and angiogenesis assay was performed. We found that HeC accelerated the migration of NRCFs and did not increase the expression of fibroblast activation markers. HeC tended to decrease mEV secretion of NRCFs, but the supernatant of HeC or the control NRCFs did not accelerate the migration of naïve NRCFs or affect the angiogenic potential of HUVEC-TERT2. In conclusion, HeC may contribute to cardioprotection by increasing fibroblast migration but not by releasing protective mEVs or soluble factors from cardiac fibroblasts.
No takes yet. Share an insight, caveat, or question.
Jelemenský et al. (2021) studied Ischemia/reperfusion injury. Helium conditioning (HeC) vs. Control NRCFs was evaluated on Fibroblast migration, activation markers, mEV secretion, and angiogenic potential. Helium conditioning accelerated the migration of neonatal rat cardiac fibroblasts but did not increase activation markers or release protective extracellular vesicles or soluble factors.
Synapse has enriched 10 related papers. Consider them for comparative context: